The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 1096
ISSUE 1096
January 22, 2001
Issue 1096
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
Fluoxetine Sarafem For Premenstrual Dysphoric Disorder
January 22, 2001 (Issue: 1096)
Fluoxetine, a selective serotonin reuptake inhibitor (SSRI) previously sold only as Prozac, is now also marketed as Sarafem for treatment of premenstrual dysphoric disorder (PMDD). Generic fluoxetine is expected to be available sometime this...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.